The Depression Treatment Gap affects Millions in South Africa
The depression treatment gap widens as modelling shows over two million people affected and major inequality in antidepressant access.
African Genome Diversity: Wits-Led AGenDA Adds 1,000 Genomes
The African Genome Diversity effort led by Wits adds 1,000+ genomes, improving AI models and precision medicine for African populations.
Long-acting Injectable PrEP: Transforming HIV Strategies
Learn how long-acting injectable PrEP can transform HIV responses in South Africa while bridging treatment access gaps.
Lenacapavir Access Under Scrutiny by Health Advocates
Explore the urgent call for lenacapavir access, as advocates seek equitable HIV prevention for all communities worldwide.
Gilead’s Lenacapavir to Reach High-Burden Nations ‘At Cost’
Gilead’s Lenacapavir is set to revolutionise HIV prevention efforts, aiming to protect two million people across affected nations.
Lenacapavir injection: The new frontier in HIV prevention
Despite its promise, access to Lenacapavir, a revolutionary HIV prevention injection which stops 100% of new HIV infections in women and girls, is restricted.